Gordin D, Hiilesmaa V, Fagerudd J, et al. Pre-eclampsia but not pregnancy-induced hypertension is a risk factor for diabetic nephropathy in type 1 diabetic women. Diabetologia 2007;50:516-522

Department of Obstetrics and Gynaecology, University of Helsinki, Helsinki, Uusimaa, Finland
Diabetologia (Impact Factor: 6.67). 03/2007; 50(3):516-22. DOI: 10.1007/s00125-006-0544-5
Source: PubMed


Our aim was to study whether pre-eclampsia and pregnancy-induced hypertension are predictors of diabetic nephropathy in type 1 diabetic women.
A total of 203 type 1 diabetic women, who were pregnant between 1988 and 1996 and followed at the Department of Obstetrics and Gynaecology in Helsinki, were re-assessed after an average of 11 years within the nationwide, multi-centre Finnish Diabetic Nephropathy Study. Diabetic nephropathy was defined as microalbuminuria, macroalbuminuria or end-stage renal disease.
Patients with prior pre-eclampsia had diabetic nephropathy more often than patients with a normotensive pregnancy (diabetic nephropathy vs normal albumin excretion rate: 41.9% vs 8.9%; p<0.001), whereas patients with a history of pregnancy-induced hypertension did not (10.3% vs 8.9%; p=0.81). CHD was more prevalent in patients with a history of pre-eclampsia than in patients with a normotensive pregnancy (12.2% vs. 2.2%; p=0.03). Pre-eclampsia (odds ratio [OR] 7.7, 95% CI 1.6-36.1; p=0.01) and HbA(1c) (OR 2.0, 95% CI 1.1-3.8; p<0.05) were associated with incident diabetic nephropathy even when adjusted for follow-up time, BMI, smoking, diabetes duration and age.
These data suggest that a history of pre-eclamptic pregnancy but not pregnancy-induced hypertension is associated with an elevated risk of diabetic nephropathy.

Download full-text


Available from: Kari Teramo, Mar 12, 2014
  • Source
    • "The pathogenesis of diabetic complications shares several potential mechanisms with these conditions, mainly endothelial dysfunction, chronic low-grade inflammation, and insulin resistance. We recently showed that pre-eclampsia is a risk factor for later development of diabetic nephropathy in women with type 1 diabetes (10). However, the association between short stature and diabetic complications is uncertain (11,12). "
    [Show abstract] [Hide abstract]
    ABSTRACT: Short adult stature has previously been associated with cardiovascular disease, but its relationship with the microvascular complications of diabetes is uncertain. Therefore, we evaluated the association between adult stature and prevalence and incidence of diabetic microvascular complications. This cross-sectional and longitudinal study comprises 3,968 adult patients with type 1 diabetes from the Finnish Diabetic Nephropathy (FinnDiane) Study and 1,246 adult patients from the Diabetes Control and Complications Trial (DCCT). In FinnDiane, diabetic nephropathy was defined as urinary albumin excretion > or = 300 mg/24 h, dialysis, or renal transplantation. Retinopathy was divided into background and proliferative (laser-treated) retinopathy. In the DCCT, original nephropathy (class 1-6) and retinopathy (Early Treatment of Diabetic Retinopathy Study) classifications were used. In the FinnDiane study, patients in the lowest quartile of adult height had increased risks of prevalent diabetic nephropathy (odds ratio [OR] 1.71, 95% CI 1.44-2.02) and prevalent laser-treated retinopathy (1.66, 1.43-1.93) compared with other patients. Similarly, in the DCCT, patients in the lowest quartile of adult height had increased risks of incident diabetic nephropathy class 4-6 (hazard ratio 2.70, 95% CI 1.59-4.59) and incident proliferative retinopathy (2.06, 1.15-3.71). In the FinnDiane study, the associations were largely explained by childhood exposure to diabetes. However, in the DCCT, where a greater proportion of patients had diabetes onset >18 years, the association with nephropathy was independent of childhood diabetes exposure. Short adult stature is associated with microvascular complications in patients with type 1 diabetes. These findings are compatible with either childhood diabetes exposure or "common soil" or both as potential explanations.
    Full-text · Article · Jun 2009 · Diabetes
  • [Show abstract] [Hide abstract]
    ABSTRACT: The ECRH experiment on TORE SUPRA is designed to inject up to 3 MW of power at 118 GHz, using an antenna consisting of six fixed spherical mirrors and three mobile steering minors. The position of the mobile mirrors can be varied in real time using two stepper motors for each mobile mirror. In addition to controlling the injection angle, the position of the mobile mirrors also affects the polarisation of the injected wave. Accurate formulae to computer in real time, the stepper motor positions required to obtain the desired beam injection angles have been derived. Formulae to determine the effect on the wave polarisation, of the actual mobile mirror positions have also been determined. These formulae have been verified by precise laser measurements and by comparison of power deposition calculations and experimental results. Experiments with different values of polarisation and injection angles have been carried out in the 2001 campaign.
    No preview · Conference Paper · Feb 2002
  • Source

    Full-text · Article · Jan 2009 · Medecine sciences: M/S
Show more